Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2026 Filed Jul 31, 2026 12:56 UTC |
Williamson Douglas JDirector
|
GrantStock Options (Right to Buy) · Derivative | 40,826 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001911501-26-000006 · form4-07312026_120720.xml · derivative · entry 1 Williamson Douglas J · CIK 0001911501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,826 Underlying: Common Stock · 40,826 shares Expires 2036-07-29 F1 · derivative.exercise_date: Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:34 UTC |
Adler Reid G.Chief Legal Officer
|
GrantCommon Stock | 36,818 | $0.19 | $7,072.74 |
DisclosureSEC source: 0001924908-26-000007 · form4-07022026_080703.xml · nonDerivative · entry 1 Adler Reid G. · CIK 0001924908 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,868 F1 · kind: Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended (the "ESPP"), in a transaction exempt under Rule 16b-3 and Rule 16b-3(d). The Reporting Person purchased the maximum amount permitted under the ESPP. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:16 UTC |
Singh ShawnDirector · President and CEO
|
GrantCommon Stock | 36,818 | $0.19 | $7,072.74 |
DisclosureSEC source: 0001412071-26-000006 · form4-07022026_080729.xml · nonDerivative · entry 1 Singh Shawn · CIK 0001412071 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,846 F1 · kind: Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended (the "ESPP"), in a transaction exempt under Rule 16b-3 and Rule 16b-3(d). The Reporting Person purchased the maximum amount permitted under the ESPP. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:17 UTC |
Tressler Nick B.Chief Financial Officer
|
GrantCommon Stock | 11,712 | $0.19 | $2,249.88 |
DisclosureSEC source: 0001794362-26-000004 · form4-07022026_080720.xml · nonDerivative · entry 1 Tressler Nick B. · CIK 0001794362 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,712 F1 · kind: Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:52 UTC |
Angelov Angel SChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0002132062-26-000004 · form4-05192026_080513.xml · derivative · entry 1 Angelov Angel S · CIK 0002132062 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2036-05-18 F2 · price: The stock options were granted in connection with the Reporting Person's appointment as Chief Medical Officer. F1 · derivative.exercise_date: 25% of the stock options vest on May 18, 2027 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:38 UTC |
Cote Elissa S.Chief Corp Development Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0002069951-26-000004 · edgardoc.xml · derivative · entry 1 Cote Elissa S. · CIK 0002069951 · Chief Corp Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:33 UTC |
Adler Reid G.Chief Legal Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 56,247 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001924908-26-000005 · edgardoc.xml · derivative · entry 2 Adler Reid G. · CIK 0001924908 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,247 Underlying: Common Stock · 56,247 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:33 UTC |
Adler Reid G.Chief Legal Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 18,753 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001924908-26-000005 · edgardoc.xml · derivative · entry 1 Adler Reid G. · CIK 0001924908 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,753 Underlying: Common Stock · 18,753 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:41 UTC |
Singh ShawnDirector · President and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 71,268 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001412071-26-000004 · edgardoc.xml · derivative · entry 2 Singh Shawn · CIK 0001412071 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,268 Underlying: Common Stock · 71,268 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:41 UTC |
Singh ShawnDirector · President and CEO
|
GrantIncentive Stock Option (right to buy) · Derivative | 3,732 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001412071-26-000004 · edgardoc.xml · derivative · entry 1 Singh Shawn · CIK 0001412071 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,732 Underlying: Common Stock · 3,732 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:43 UTC |
Tressler Nick B.Chief Financial Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001794362-26-000002 · edgardoc.xml · derivative · entry 1 Tressler Nick B. · CIK 0001794362 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:40 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 56,248 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001998663-26-000006 · edgardoc.xml · derivative · entry 2 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,248 Underlying: Common Stock · 56,248 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| April 07, 2026 Filed Apr 10, 2026 00:40 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 18,752 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001998663-26-000006 · edgardoc.xml · derivative · entry 1 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,752 Underlying: Common Stock · 18,752 shares Expires 2036-04-07 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 01:51 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantCommon Stock | 4,386 | $0.56 | $2,467.56 |
DisclosureSEC source: 0001998663-26-000002 · edgardoc.xml · nonDerivative · entry 1 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,249 F1 · shares: Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 11:07 UTC |
Tressler Nick B.Chief Financial Officer
|
GrantCommon Stock (Right to Buy) · Derivative | 150,000 | Not disclosed Strike: $4.43 | Not disclosed |
DisclosureSEC source: 0001794362-25-000005 · form4-12042025_111200.xml · derivative · entry 1 Tressler Nick B. · CIK 0001794362 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2035-12-01 F2 · price: The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer. F1 · derivative.exercise_date: 25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. Read SEC document |
| October 27, 2025 Filed Nov 4, 2025 21:34 UTC |
Edick Paul RDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,200 | Not disclosed Strike: $3.90 | Not disclosed |
DisclosureSEC source: 0001531178-25-000007 · form4-11042025_091145.xml · derivative · entry 1 Edick Paul R · CIK 0001531178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,200 Underlying: Common Stock · 35,200 shares Expires 2035-10-27 F1 · kind: Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant. F1 · price: Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant. F1 · derivative.exercise_date: Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 18:15 UTC |
Rotunno Mary L.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,600 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001411685-25-000077 · edgardoc.xml · derivative · entry 1 Rotunno Mary L. · CIK 0001869200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-09-09 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 18:15 UTC |
SAXE JON SDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,600 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001411685-25-000078 · edgardoc.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-09-09 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 22:15 UTC |
FitzPatrick Margaret MDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,600 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001411685-25-000076 · edgardoc.xml · derivative · entry 1 FitzPatrick Margaret M · CIK 0001873879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-09-09 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 22:14 UTC |
Cunningham Ann MichelleDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,600 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001411685-25-000074 · edgardoc.xml · derivative · entry 1 Cunningham Ann Michelle · CIK 0001764572 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-09-09 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 22:14 UTC |
Curley JoanneDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,600 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001411685-25-000075 · edgardoc.xml · derivative · entry 1 Curley Joanne · CIK 0001857670 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-09-09 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:50 UTC |
Adler Reid G.Chief Legal Officer
|
GrantCommon Stock | 7,541 | $1.70 | $12,819.70 |
DisclosureSEC source: 0001415889-25-018755 · form4-07012025_090738.xml · nonDerivative · entry 1 Adler Reid G. · CIK 0001924908 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,050 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:48 UTC |
Singh ShawnDirector · President and CEO
|
GrantCommon Stock | 7,541 | $1.70 | $12,819.70 |
DisclosureSEC source: 0001415889-25-018748 · form4-07012025_090724.xml · nonDerivative · entry 1 Singh Shawn · CIK 0001412071 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,028 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:51 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantCommon Stock | 4,882 | $1.70 | $8,299.40 |
DisclosureSEC source: 0001415889-25-018759 · form4-07012025_090735.xml · nonDerivative · entry 1 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,863 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:49 UTC |
Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 6,617 | $1.70 | $11,248.90 |
DisclosureSEC source: 0001415889-25-018751 · form4-07012025_090741.xml · nonDerivative · entry 1 Anderson Cynthia Lynn · CIK 0001989905 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,801 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:16 UTC |
Cote Elissa S.Chief Corp Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-25-018206 · form4-06252025_090633.xml · derivative · entry 1 Cote Elissa S. · CIK 0002069951 · Chief Corp Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2035-06-23 F2 · price: The stock options were granted in connection with the Reporting Person's appointment as Chief Corporate Development Officer. F1 · derivative.exercise_date: 25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:15 UTC |
Adler Reid G.Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-25-018201 · form4-06252025_050603.xml · derivative · entry 1 Adler Reid G. · CIK 0001924908 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:15 UTC |
Singh ShawnDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-25-018200 · form4-06252025_050601.xml · derivative · entry 1 Singh Shawn · CIK 0001412071 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:15 UTC |
Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-25-018203 · form4-06252025_050607.xml · derivative · entry 1 Anderson Cynthia Lynn · CIK 0001989905 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:15 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001415889-25-018202 · form4-06252025_050605.xml · derivative · entry 1 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. Read SEC document |
| December 31, 2024 Filed Jan 13, 2025 22:40 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantCommon Stock | 3,310 | $2.51 | $8,299.83 |
DisclosureSEC source: 0001415889-25-001402 · form4-01132025_100154.xml · nonDerivative · entry 1 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,981 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| December 31, 2024 Filed Jan 13, 2025 22:39 UTC |
Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 2,592 | $2.51 | $6,499.44 |
DisclosureSEC source: 0001415889-25-001396 · form4-01132025_100126.xml · nonDerivative · entry 1 Anderson Cynthia Lynn · CIK 0001989905 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,184 F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:00 UTC |
Rotunno Mary L.Director
|
GrantStock Option (Right to Buy) · Derivative | 14,100 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001415889-24-023144 · form4-09102024_050901.xml · derivative · entry 1 Rotunno Mary L. · CIK 0001869200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 14,100 shares Expires 2034-09-06 F1 · derivative.exercise_date: Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:00 UTC |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,100 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001415889-24-023148 · form4-09102024_050909.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 14,100 shares Expires 2034-09-06 F1 · derivative.exercise_date: Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:00 UTC |
SAXE JON SDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,100 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001415889-24-023149 · form4-09102024_050911.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 14,100 shares Expires 2034-09-06 F1 · derivative.exercise_date: Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 21:00 UTC |
Curley JoanneDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,100 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001415889-24-023147 · form4-09102024_050907.xml · derivative · entry 1 Curley Joanne · CIK 0001857670 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 14,100 shares Expires 2034-09-06 F1 · derivative.exercise_date: Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 21:00 UTC |
Cunningham Ann MichelleDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,100 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001415889-24-023146 · form4-09102024_050905.xml · derivative · entry 1 Cunningham Ann Michelle · CIK 0001764572 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 14,100 shares Expires 2034-09-06 F1 · derivative.exercise_date: Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 21:00 UTC |
FitzPatrick Margaret MDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,100 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001415889-24-023145 · form4-09102024_050903.xml · derivative · entry 1 FitzPatrick Margaret M · CIK 0001873879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,100 Underlying: Common Stock · 14,100 shares Expires 2034-09-06 F1 · derivative.exercise_date: Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 22:07 UTC |
Adler Reid G.CHF CORP DEVEL OFF, GEN COUNS
|
GrantCommon Stock | 4,854 | $2.96 | $14,358.13 |
DisclosureSEC source: 0001415889-24-019022 · form4-07022024_100750.xml · nonDerivative · entry 1 Adler Reid G. · CIK 0001924908 · CHF CORP DEVEL OFF, GEN COUNS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,509 F1 · shares: Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 22:06 UTC |
Singh ShawnDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 4,854 | $2.96 | $14,358.13 |
DisclosureSEC source: 0001415889-24-019020 · form4-07022024_100738.xml · nonDerivative · entry 1 Singh Shawn · CIK 0001412071 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,487 F1 · shares: Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 22:10 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantCommon Stock | 2,671 | $2.96 | $7,900.82 |
DisclosureSEC source: 0001415889-24-019028 · form4-07022024_100701.xml · nonDerivative · entry 1 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,671 F1 · shares: Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 22:08 UTC |
Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 3,592 | $2.96 | $10,625.14 |
DisclosureSEC source: 0001415889-24-019024 · form4-07022024_100748.xml · nonDerivative · entry 1 Anderson Cynthia Lynn · CIK 0001989905 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,592 F1 · shares: Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. Read SEC document |
| June 24, 2024 Filed Jun 27, 2024 01:30 UTC |
Adler Reid G.CHF CORP DEVEL OFF, GEN COUNS
|
GrantStock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001415889-24-018278 · form4-06272024_010654.xml · derivative · entry 1 Adler Reid G. · CIK 0001924908 · CHF CORP DEVEL OFF, GEN COUNS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2034-06-24 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. Read SEC document |
| June 24, 2024 Filed Jun 27, 2024 01:31 UTC |
Singh ShawnDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001415889-24-018279 · form4-06272024_010639.xml · derivative · entry 1 Singh Shawn · CIK 0001412071 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2034-06-24 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. Read SEC document |
| June 24, 2024 Filed Jun 27, 2024 01:30 UTC |
Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001415889-24-018277 · form4-06272024_010602.xml · derivative · entry 1 Anderson Cynthia Lynn · CIK 0001989905 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-06-24 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. Read SEC document |
| June 24, 2024 Filed Jun 27, 2024 01:29 UTC |
Prince Joshua S.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0001415889-24-018276 · form4-06272024_010600.xml · derivative · entry 1 Prince Joshua S. · CIK 0001998663 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-06-24 F1 · derivative.exercise_date: Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 18:00 UTC |
Rotunno Mary L.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-24-007099 · form4-03062024_060318.xml · derivative · entry 1 Rotunno Mary L. · CIK 0001869200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-03-04 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 18:00 UTC |
GIN JERRY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-24-007098 · form4-03062024_060314.xml · derivative · entry 1 GIN JERRY B · CIK 0000901014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-03-04 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 18:00 UTC |
SAXE JON SDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-24-007094 · form4-03062024_060301.xml · derivative · entry 1 SAXE JON S · CIK 0001114914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-03-04 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:00 UTC |
FitzPatrick Margaret MDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-24-007097 · form4-03062024_060311.xml · derivative · entry 1 FitzPatrick Margaret M · CIK 0001873879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-03-04 F1 · derivative.exercise_date: Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.